Hydrochlorothiazide
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-23-D-0003
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support has issued an award notice for a national contract, identified as SPE2D2-23-D-0003, for the supply of Hydrochlorothiazide tablets. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating drugs and biologicals.
The primary objective of this contract is to ensure a reliable and consistent supply of Hydrochlorothiazide tablets, a widely used pharmaceutical product, to meet the ongoing needs of federal agencies and military operations. The scope of the contract encompasses the manufacturing, packaging, and delivery of these tablets in accordance with stringent federal quality and safety standards. The intended outcome is to maintain an uninterrupted supply chain for this essential medication, supporting the health and readiness of service members and other authorized recipients.
The place of performance for this contract is specified as Fairfield, New Jersey, United States. Contractors engaged in this opportunity are expected to have robust pharmaceutical manufacturing capabilities, with the ability to comply with all applicable regulatory requirements for drug production and distribution within the United States.
DLA Troop Support, a federal office, serves as the contracting entity for this procurement. The primary point of contact for inquiries related to this contract is Ryan Ferry, who can be reached at [email protected] or by phone at 215-737-3182. A secondary contact is Jason Wray, available at [email protected] or 215-737-0614.
This award notice is currently active and was posted on September 27, 2023. Interested parties can access further details and related attachments through the official SAM.gov opportunity page at https://sam.gov/opp/663489a7b64b4a71ab0bffd8ef5812ce/view.
Contractors considering this opportunity should note that it is a national-level contract for a critical pharmaceutical product, requiring adherence to federal manufacturing standards and the ability to deliver within the specified location. The contract does not specify any set-aside requirements or special considerations in the provided information. All communications and clarifications should be directed to the designated DLA Troop Support contacts.
This summary provides a comprehensive overview of the contract’s purpose, scope, and key requirements, enabling potential contractors to assess alignment with their manufacturing capabilities and compliance infrastructure.
Documents6